Stocks and Investing
by (remove) : Catherine Schulte
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Catherine Schulte
RSSJSONXMLCSV
Thu, August 8, 2024
Mon, July 29, 2024
Thu, July 25, 2024
Thu, May 30, 2024
Thu, May 2, 2024
Mon, April 29, 2024
Thu, April 25, 2024
Mon, April 22, 2024
Wed, February 28, 2024
Thu, February 15, 2024
Mon, January 29, 2024
Thu, December 14, 2023
Tue, November 21, 2023
Thu, October 26, 2023
Mon, October 23, 2023
Wed, August 16, 2023
Mon, July 31, 2023
Thu, July 27, 2023
Wed, July 19, 2023
Wed, May 24, 2023
Thu, May 4, 2023
Mon, May 1, 2023
Thu, April 27, 2023
Wed, March 1, 2023
Mon, February 6, 2023
Wed, February 1, 2023
Tue, November 22, 2022
Mon, November 21, 2022
Mon, October 31, 2022

Catherine Schulte Maintained (TECH) at Buy with Increased Target to $82 on, Aug 8th, 2024


Published on 2024-10-28 13:24:44 - WOPRAI, Catherine Schulte
  Print publication without navigation


Catherine Schulte of Baird, Maintained "Bio-Techne Corporation" (TECH) at Buy with Increased Target from $81 to $82 on, Aug 8th, 2024.

Catherine has made no other calls on TECH in the last 4 months.



There are 3 other peers that have a rating on TECH. Out of the 3 peers that are also analyzing TECH, 1 agrees with Catherine's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Patrick Donnelly of "Citigroup" Downgraded from Strong Buy to Hold and Held Target at $85 on, Wednesday, May 22nd, 2024


These are the ratings of the 2 analyists that currently disagree with Catherine


  • Robert Wasserman of "Benchmark" Reiterated at Strong Buy and Held Target at $95 on, Thursday, May 2nd, 2024
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $82 on, Thursday, April 18th, 2024
Contributing Sources